cAMP (Cyclic Adenosine Monophosphate) Levels in the Nose
cAMP Levels in the Nose
1 other identifier
interventional
41
1 country
1
Brief Summary
The purpose of this study is to determine the normal distribution of nasal tissue cathelicidin antimicrobial peptides (cAMP) levels in subjects with normal smell and subjects with smell dysfunction. The investigators will also look at the effect of nasal saline irrigation on olfaction and cAMP levels and if nasal irrigation is capable of harvesting olfactory cilia. The investigators hypothesize that nasal saline will have no effect on olfaction and will be inadequate to harvest olfactory cilia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2011
CompletedFirst Submitted
Initial submission to the registry
April 7, 2011
CompletedFirst Posted
Study publicly available on registry
April 11, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedDecember 12, 2013
December 1, 2013
7 months
April 7, 2011
December 11, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
UPSIT
validated, scratch and sniff smell identification test
7 days
Study Arms (3)
olfactory dysfunction
NO INTERVENTIONsubjects diagnosed with olfactory dysfunction
normal olfaction, no saline
NO INTERVENTIONno smell dysfunction, not randomized to saline nasal irrigation for 7 days
normal olfaction
OTHERnormal olfaction, randomized to saline nasal irrigation for 7 days
Interventions
Eligibility Criteria
You may qualify if:
- Normal olfactory function cohort:
- self-reported normal smell function
- age greater than 18 years
- Olfactory dysfunction cohort:
- ICD9 diagnostic code for olfactory dysfunction
- idiopathic olfactory dysfunction
- age greater than 18 years
You may not qualify if:
- allergy to lidocaine
- active upper respiratory infection
- previous nasal or sinus surgery
- current tobacco use
- unable to give consent due to language barrier, cognitive or medical issues
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Washington
Seattle, Washington, 98105, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Greg E Davis, MD, MPH
University of Washington
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 7, 2011
First Posted
April 11, 2011
Study Start
March 1, 2011
Primary Completion
October 1, 2011
Study Completion
December 1, 2012
Last Updated
December 12, 2013
Record last verified: 2013-12